Min Peng

882 total citations
60 papers, 521 citations indexed

About

Min Peng is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Min Peng has authored 60 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Min Peng's work include Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Ferroptosis and cancer prognosis (9 papers). Min Peng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Ferroptosis and cancer prognosis (9 papers). Min Peng collaborates with scholars based in China and United States. Min Peng's co-authors include Qibin Song, Yiming Weng, Qi Song, Yi Yao, Bin Xu, Jia Feng, Xuechun Zhang, Pengcheng Luo, Shaoyong Ke and Liqiao Shi and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Min Peng

56 papers receiving 517 citations

Peers

Countries citing papers authored by Min Peng

Since Specialization

Citations

This map shows the geographic impact of Min Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Peng more than expected).

Fields of papers citing papers by Min Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Peng. The network helps show where Min Peng may publish in the future.

Co-authorship network of co-authors of Min Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Min Peng. A scholar is included among the top collaborators of Min Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Peng. Min Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[Tiaoshen Guben holistic therapy of acupuncture and moxibustion for 24 cases of comorbidity of depression and insomnia]. 2025 ·PubMed ·Zhongxian Li, Pan Zhang, (unknown), Min Peng, Zhen Jiao, Yifu Zhou, Jingwei Liang, (unknown), Wenbin Fu, (unknown)	0
2	Identification and analysis of cuproptosis associated molecular clusters and immunological profiles in atopic dermatitis 2025 ·Frontiers in Immunology ·(unknown), (unknown), Min Peng, Xiaoyan Yang, Sijia Huang, Ruixin Wang, Lin Du, (unknown), Wei Wang, (unknown), (unknown)	1
3	Estrogen Induces LCAT to Maintain Cholesterol Homeostasis and Suppress Hepatocellular Carcinoma Development 2024 ·Cancer Research ·Wenzhi He, (unknown), Xuechun Zhang, (unknown), (unknown), (unknown), Fang Lei, Min Peng, Zhonglin Zhang, (unknown), Zan Huang	21
4	Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages 2024 ·Nature Communications ·Rui Sun, Chao Lei, Zhishan Xu, Xuemei Gu, Liu Huang, Liang Chen, Yi Tan, Min Peng, Kavitha Yaddanapudi, Leah J. Siskind, Maiying Kong, Robert A. Mitchell, Jun Yan, Zhongbin Deng	16
5	Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancer 2024 ·Aging ·Jinsong Wang, Jia Feng, Xinyi Chen, Yiming Weng, Tong Wang, (unknown), (unknown), Min Peng	6
6	Abstract CT204: Safety, tolerability, pharmacokinetics, and efficacy of SHR-A1811, an antibody-drug conjugate, in patients with advanced HER2-mutant non-small cell lung cancer (NSCLC): a multicenter, open-label, phase 1/2 study 2023 ·Cancer Research ·Shun Lü, (unknown), Wei Hong, (unknown), Nong Yang, Sheng Hu, Zibin Liang, Yongsheng Wang, Yan Wang, Min Peng, Yan Yu, You Li, (unknown), Kaijing Zhao	2
7	Identification of the Prognostic Biomarkers CBX6 and CBX7 in Bladder Cancer 2023 ·Diagnostics ·(unknown), Lili Li, (unknown), (unknown), Min Peng, Kai Zhu, Pengcheng Luo	6
8	Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy 2023 ·Frontiers in Genetics ·Jinsong Wang, (unknown), Yiming Weng, (unknown), Xinyi Chen, (unknown), Tong Wang, Jian Qin, Min Peng	4
9	Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer 2023 ·Frontiers in Oncology ·(unknown), Chen Chen, Xinxin Li, Jun Yang, Wei Zhang, (unknown), Hong Zhang, Min Peng, Lili Li, Pengcheng Luo	12
10	A Novel Risk Model for lncRNAs Associated with Oxidative Stress Predicts Prognosis of Bladder Cancer 2022 ·Journal of Oncology ·Lixiang Feng, Kang Yang, (unknown), Min Peng, Lili Li, Pengcheng Luo	5
11	Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma 2022 ·Journal of Hepatology ·Jiaqi Sun, Jun Ding, (unknown), Xiyang Wang, Min Wang, Yongping Huang, Xuechun Zhang, (unknown), Feng Zhang, Dongde Wu, Min Peng, Zhonglin Zhang, Yufeng Yuan, Wenhua Li, Zhi‐Gang She, Xiao‐Jing Zhang, Hongliang Li, Peng Zhang, (unknown)	31
12	Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis 2022 ·Frontiers in Oncology ·(unknown), (unknown), Yiming Weng, Jia Feng, (unknown), (unknown), (unknown), Xinyi Chen, Jinsong Wang, Min Peng	10
13	Genome-wide survey identifies TNNI2 as a target of KLF7 that inhibits chicken adipogenesis via downregulating FABP4 2022 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·(unknown), Hu Xu, Jinwei Li, Min Peng, (unknown), (unknown), (unknown), Shu‐Li Shao, Weiwei Zhang, Weiyu Wang	6
14	Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis 2021 ·Journal of Oncology ·(unknown), Jia Feng, Yiming Weng, (unknown), Min Peng	13
15	<p>Circulating Tumor Cell Detection In Epithelial Ovarian Cancer Using Dual-Component Antibodies Targeting EpCAM And FRα</p> 2020 ·Cancer Management and Research ·(unknown), (unknown), (unknown), (unknown), Jin Zhou, Yi Yao, Bin Xu, Hongyun Gong, Yiming Weng, Qinyong Hu, Qibin Song, Min Peng, Yanxiang Cheng	11
16	Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer 2020 ·The Oncologist ·Liang Jin, Kai Chen, Cui Tan, Jianbin Li, (unknown), Yaping Yang, Yudong Li, Shunying Li, Liling Zhu, Yue Hu, Fengtao Liu, (unknown), Min Peng, Zefei Jiang, Qiang Liu	6
17	Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases 2020 ·Frontiers in Oncology ·Xiaofang Ying, (unknown), Ming‐Wei Wang, Min Peng, (unknown), Vivek Verma, Guang Han	5
18	GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer 2016 ·American Journal Of Pathology ·Zheqiong Yang, Min Peng, Liang Cheng, (unknown), Nita J. Maihle, Nahid F. Mivechi, Lan Ko	12
19	Circulating MicroRNA Let-7d in Attention-Deficit/Hyperactivity Disorder 2015 ·NeuroMolecular Medicine ·(unknown), Min Peng, Mei Yu, Qian Zhao, Chao Li, Yu Jin, Yong Jiang, (unknown), (unknown), Hui Sun, Xing Wu	37
20	An MLH1 Mutation Links BACH1/FANCJ to Colon Cancer, Signaling, and Insight toward Directed Therapy 2010 ·Cancer Prevention Research ·Jenny Xie, Shawna Guillemette, Min Peng, Candace A. Gilbert, Andrew B. Buermeyer, Sharon B. Cantor	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact